A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies

Mathematical Medicine and Biology

Volumn 20, Issue 2, 2003, Pages 135-181

  Plank, M J ^a   Sleeman, B D ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiogenesis; ; Angiostatin, chemotaxis; Haptotaxis; Reinforced random walk; Tumour

Indexed keywords

BLOOD VESSELS; ENDOTHELIAL CELLS; RANDOM PROCESSES; REINFORCEMENT; TUMORS;

ANGIOGENESIS; ANGIOGENESIS;; ANGIOSTATIN; ANGIOSTATIN, CHEMOTAXI; CHEMOTAXI; HAPTOTAXI; RANDOM WALK; RANDOM WALK MODELING; REINFORCED RANDOM WALK; TUMOR ANGIOGENESIS;

BIOCHEMISTRY;

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; GROWTH FACTOR; PROTEINASE; VASCULOTROPIN;

ANASTOMOSIS; ANGIOGENESIS; ARTICLE; CAPILLARY; CELL PROLIFERATION; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPERIMENTATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; PREDICTION; PROTEIN DEGRADATION; QUALITATIVE ANALYSIS; RANDOMIZATION; TUMOR; VASCULARIZATION;

EID: 0042863949     PISSN: 14778599     EISSN: None     Source Type: Journal    
DOI: 10.1093/imammb/20.2.135     Document Type: Article

References (77)

1. Anderson, A. R. A. & Chaplain, M. A. J. (1998) Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull. Math. Biol., 60, 857-900.
2. Anderson, A. R. A., Chaplain, M. A. J., Newman, E. L., Steele, R. J. C. & Thompson, A. M. (2000) Mathematical modelling of tumour invasion and metastasis. J. Theor. Med., 2, 129-154.
3. Anderson, A. R. A., Sleeman, B. D., Young, I. M. & Griffiths, B. S. (1997) Nematode movement along a chemical gradient in a structurally heterogeneous environment: 2. Theory. Fund. Appl. Nematol., 20, 165-172.
4. Ausprunk, D. H. & Folkman, J. (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc. Res., 14, 53-65.
5. Balding, D. & McElwain, D. L. S. (1985) Mathematical modelling of tumour-induced capillary growth. J. Theor. Biol., 114, 53-73.
6. Birdwell, C. R., Gospodarowicz, D. & Nicolson, G. L. (1978) Identification, localisation and role of fibronectin in cultured bovine endothelial cells. Proc. Natl Acad. Sci. USA, 75, 3273-3277.
7. Bowersox, J.C. & Sorgente, N. (1982) Chemotaxis of aortic endothelial cells in response to fibronectin. Canc. Res., 42, 2547-2551.
8. Burke, P. A. & DeNardo, S. J. (2001) Antiangiogenic agents and their promising potential in combined therapy. Crit. Rev. Oncol. Hematol., 39, 155-171.
9. Byrne, H. M. & Chaplain, M. A. J. (1995) Mathematical models for tumour angiogenesis: Numerical simulations and nonlinear wave solutions. Bull. Math. Biol., 57, 461-486.
10. Cao, Y. (2001) Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell Biol., 33, 357-369.
11. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nature Med., 6, 389-395.
12. Carmeliet, P. & Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature, 407, 249-257.
13. Carney, D. H. & Cunningham, D. D. (1977) Initiation of chick cell division by trypsin action at the cell surface. Nature, 268, 602-606.
14. Carter, S. B. (1965) Principles of cell motility: The direction of cell movement and cancer invasion. Nature, 208, 1183-1187.
15. Cavallaro, U. & Christofori, G. (2000) Molecular mechanisms of tumour angiogenesis and tumour progression. J. Neuro-Oncol., 50, 63-70.
16. Chaplain, M. A. J., Giles, S. M., Sleeman, B. D. & Jarvis, R. J. (1995) A mathematical model for tumour angiogenesis. J. Math. Biol., 33, 744-770.
17. Chaplain, M. A. J. & Stuart, A. M. (1993) A model mechanism for the chemotactic response of endothelial cells to tumour angiogenesis factor. IMA J. Math. Appl. Med. Biol., 10, 149-168.
18. Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O'Reilly, M. & Folkman, J. (1998) Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif rgd. Proc. Natl Acad. Sci. USA, 95, 5579-5583.
19. Clark, R. A. F., DellaPelle, P., Manseau, E., Lanigan, J. M., Dvorak, H. F. & Colvin, R. B. (1982) Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J. Invest. Dermatol., 79, 269-276.
20. Clark, R. A. F., Dvorak, H. F. & Colvin, R. B. (1981) Fibronectin in delayed-type hypersensitivity skin reactions: Associations with vessel permeability and endothelial cell activation. J. Immunol., 126, 787-793.
21. Davis, B. (1990) Reinforced random walk. Prob. Th. Rel. Fields, 84, 203-229.
22. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C. & Yancopoulos, G. D. (1996) Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell, 87, 1161-1169.
23. Denekamp, J. & Hobson, B. (1982) Endothelial cell proliferation in experimental tumours. Brit. J. Canc., 46, 711-720.
24. Firmani, B., Guerri, L. & Preziosi, L. (1999) Tumour/immune system competition with medically induced activation/deactivation. Math. Models and Methods in Appl. Sci., 9, 491-512.
25. Folkman, J. (1971) Tumour angiogenesis: Therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
26. Folkman, J. (1974) Tumour angiogenesis. Adv. Canc. Res., 19, 331-358.
27. Folkman, J. & Klagsbrun, M. (1987) Angiogenic factors. Sci., 235, 442-447.
28. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., Volpert, O., Bouck, N. & Soff, G. A. (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl Acad. Sci. USA, 94, 10868-10872.
29. Gately, S., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L., Cundiff, D. L., Schnaper, H. W., Madison, L., Volpert, O., Bouck, N., Enghild, J., Kwaan, H. C. & Soff, G. A. (1996) Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res., 56, 4887-4890.
30. Giordano, F. J. & Johnson, R. S. (2001) Angiogenesis: The role of the microenvironment in flipping the switch. Curr. Opin. Genet. Dev., 11, 35-40.
31. Han, Z. C. & Liu, Y. (1999) Angiogenesis: State of the art. Int. J. Hematol., 70, 68-82.
32. Hanahan, D. & Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell, 86, 353-364.
33. Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K. & McDonald, D. M. (2000) Openings between defective endothelial cells explain tumour vessel leakiness. Am. J. Pathol., 156, 1363-1380.
34. Holmes, M. J. & Sleeman, B. D. (2000) A mathematical model of tumour angiogenesis incorporating cellular traction and viscoelastic effects. J. Theor. Biol., 202, 95-112.
35. Hunt, T. K., Knighton, D. R., Thakral, K. K., Goodson, W. H. & Andrews, W. S. (1984) Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated macrophages. Surgery, 96, 48-54.
36. Jones, P. F. (1997) Tied up (or down?) with angiopoietins. Angiogenesis, 1, 38-44.
37. Kendall, R. L., Rutledge, R. Z., Mao, X., Tebben, A. J., Hungate, R. W. & Thomas, K. A. (1999) Vacular endothelial growth factor receptor kdr tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J. Biol. Chem., 274, 6453-6460.
38. Kirsch, M., Schackert, G. & Black, P. M. (2000) Angiogenesis, metastasis and endogenous inhibition. J. Neuro-Oncol., 50, 173-180.
39. Klagsbrun, M. & D'Amore, P. A. (1996) Vascular endothelial growth factor and its receptors. Cytokine Growth Fact. Rev., 7, 259-270.
40. Lai, W. H., Cameron, P. H., Wada, I., Doherty, J. J., Kay, D. G., Posner, B. I. & Bergeron, J. J. M. (1989) Ligand-mediated internalisation, recycling and downregulation of the epidermal growth factor receptor in vivo. J. Cell Biol., 109, 2741-2749.
41. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. & Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Sci., 246, 1306-1309.
42. Levine, H. A., Sleeman, B. D. & Nilsen-Hamilton, M. (2000) A mathematical model of the roles of pericytes and macrophages in the initiation of angiogensis: I. The role of protease inhibitors in preventing angiogenesis. Math. Biosciences, 168, 77-115.
43. Levine, H. A., Pamuk, S., Sleeman, B. D. & Nilsen-Hamilton, M. (2001a) A mathematical model of capillary formation and development in tumour angiogenesis: Penetration into the stroma. Bull. Math. Biol., 63, 801-863.
44. Levine, H. A., Sleeman, B. D. & Nilsen-Hamilton, M. (2001b) Mathematical modelling of the onset of capillary formation initiating angiogenesis. J. Math. Biol., 42, 195-238.
45. Levine, H. A., Tucker, A. L. & Nilsen-Hamilton, M. (2003) A mathematical model for the role of cell signal transduction in the initiation and inhibition of angiogenesis. Growth Factors, 20, 155-175.
46. Liotta, L. A., Steeg, P. S. & Stetler-Stevenson, W. G. (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 64, 327-336.
47. Liu, W., Ahmad, S. A., Reinmuth, N., Shaheen, R. M., Jung, Y. D., Fan, F. & Ellis, L. M. (2000) Endothelial cell survival and apoptosis in the tumour vasculature. Apoptosis, 5, 323-328.
48. Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S. J., Borlat, F., Sim, B. K. L., Wu, Z., Grau, G. E., Shing, Y., Soff, G. A., Bouck, N. & Pepper, M. S. (1998) Multiple formas of angiostatin induce apoptosis in endothelial cells. Blood, 92, 4730-4741.
49. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papandopoulos, N., Daly, T. J., Davis, S. & Sato, T. N. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Sci., 277, 55-60.
50. Moser, T. L., Stack, M. S., Wahl, M. L. & Pizzo, S. V. (2002) The mechanism of action of angiostatin: Can you teach an old dog new tricks? Thromb. Haemost., 87, 394-401.
51. Murray, J. D. (1993) Mathematical Biology (2nd ed.). Berlin: Springer.
52. Muthukkaruppan, V. R. & Auerbach, R. (1979) Angiogenesis in the mouse cornea. Sci., 205, 1416-1418.
53. Muthukkaruppan, V. R., Kubai, L. & Auerbach, R. (1982) Tumour-induced neovascularization in the mouse eye. J. Natl Canc. Inst., 69, 699-708.
54. Nicosia, R. F., Bonanno, E. & Smith, M. (1993) Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J. Cell. Physiol., 154, 654-661.
55. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the supression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328.
56. Othmer, H. G. & Stevens, A. (1997) Aggregation, blowup and collapse: The ABC's of taxis and reinforced random walks. SIAM J. Appl. Math., 57, 1044-1081.
57. Papetti, M. & Herman, I. M. (2002) Mechanisms of normal and tumour-derived angiogenesis. Am. J. Physiol. Cell Physiol., 282, C947-C970.
58. Paweletz, N. & Kneirim, M. (1989) Tumour related angiogenesis. Crit. Rev. Oncol. Haematol., 9, 197-242.
59. Pepper, M. S. (1997) Manipulating angiogenesis. Arterio. Thromb. Vasc. Biol., 17, 605-619.
60. Pepper, M. S. (2001) Extracellular proteolysis and angiogenesis. Thromb. Haemost., 86, 346-355.
61. Pepper, M. S., Belin, D., Montesano, R., Orci, L. & Vassalli, J. D. (1990) Transforming growth factor-β1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol., 111, 743-755.
62. Reynolds, L. P., Killilea, S. D. & Redmer, D. A. (1992) Angiogenesis in the female reproductive cycle. FASEB J., 6, 886-892.
63. Risau, V. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674.
64. Schirrmacher, V. (1985) Cancer metastasis: Experimental approaches, theoretical concepts and impacts for treatment strategies. Adv. Canc. Res., 43, 1-73.
65. Schnell, S. & Mendoza, C. (1997) Closed form solution for time-dependent enzyme kinetics. J. Theor. Biol., 187, 207-212.
66. Semenza, G. L. (2000) HIF-1: Using two hands to flip the angiogenic switch. Canc. Metast. Rev., 19, 59-65.
67. Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L. & Wilson, J. D. (1984) Mechanisms of neovascularization. Lab. Invest., 51, 624-634.
68. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
69. Sleeman, B. D. & Wallis, I. P. (2002) Tumour induced angiogenesis as a reinforced random walk: Modelling capillary network formation without endothelial cell proliferation. J. Math. Comp. Modelling, 36, 339-358.
70. Soff, G. A. (2000) Angiostatin and angiostatin-related proteins. Canc. Metastasis Rev., 19, 97-107.
71. Stack, M. S., Gately, S., Bafetti, L. M., Enghild, J. J. & Soff, G. A. (1999) Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem. J., 340, 77-84.
72. Stokes, C. L. & Lauffenburger, D. A. (1991) Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J. Theor. Biol., 152, 377-403.
73. Turner, S. & Sherratt, J. A. (2002) Intercellular adhesion and cancer invasion: A discrete simulation using the extended potts model. J. Theor. Biol., 216, 85-100.
74. Unemori, E. N., Ferrara, N., Bauer, E. A. & Amento, E. P. (1992) Vascular endothelial growth factor induces interstital collagenase expression in human endothelial cells. J. Cell. Physiol., 153, 557-562.
75. Vajkoczy, P., Farhadi, M., Gaumann, A., Heidenreich, R., Erber, R. G., Wunder, A., Tonn, J. C., Menger, M. D. & Breier, G. (2002) Microtumour growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2 and angiopoietin-2. J. Clin. Invest., 109, 777-785.
76. Vernon, R. B. & Sage, E. H. (1999) A novel quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc. Res., 57, 118-133.
77. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. & Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-249.